Clinical Trial Update: Bevacizumab to Treat Kaposi's Sarcoma in HIV-Positive and HIV-Negative Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating bevacizumab for Kaposi's sarcoma in HIV-positive and HIV-negative individuals has completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Kaposi Sarcoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kaposi's Sarcoma, HIV Infections | Phase 2 | Status: COMPLETED | Results posted: 2012-07-26